-transparent.png){kind=logo}
The immune reactivity of 50 patients with solid tumors before therapeutic treatment and 26 healthy controls was assessed by both in vitro and in vivo tests. No significant differences between controls and patients were found in peripheral lymphocyte counts or in delayed hypersensitivity to recall antigens. However, impairment of lymphocyte stimulation with phytohemagglutinin (PHA) and a decrease in the number of E-rosette forming cells (E RFC) were detected in cancer-bearing patients irrespective of tumor type. The results of the present study further confirm the usefulness of the PHA and E-RFC tests in monitoring the immune competence of cancer patients.
Related Publications
E Menconi, and
A Barzi, and
M Greco
January 1985,
Contemporary topics in immunobiology,
E Menconi, and
A Barzi, and
M Greco
January 1974,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
E Menconi, and
A Barzi, and
M Greco
January 1977,
Developments in biological standardization,
E Menconi, and
A Barzi, and
M Greco
January 1980,
Contemporary topics in immunobiology,
E Menconi, and
A Barzi, and
M Greco
May 1978,
Vnitrni lekarstvi,
E Menconi, and
A Barzi, and
M Greco
January 1974,
Oncology,
E Menconi, and
A Barzi, and
M Greco
February 1969,
Annals of internal medicine,
E Menconi, and
A Barzi, and
M Greco
February 1979,
Recenti progressi in medicina,
E Menconi, and
A Barzi, and
M Greco
January 1978,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
E Menconi, and
A Barzi, and
M Greco
September 1989,
Vestnik khirurgii imeni I. I. Grekova,
